News

Strategic investments, workforce readiness, and pioneering initiatives are attracting leading life sciences companies to ...
Eli Lilly and Company has announced plans to bolster its domestic ... New sites in Research Triangle Park and Concord, North Carolina New sites at the LEAP Innovation District in Lebanon, Indiana ...
Eli Lilly has raised its revenue guidance ... In its update, Ricks said a new facility at Concord in North Carolina – part of an $18 billion investment programme launched in 2020 – is being ...
Lilly Bandy, Staunton ... Quinn Morrow/Camden Earley, North Mac: The pitcher struck out 10 and allowed one run on four hits and a walk in a complete-game 3-1 win over Carrollton.
In fall 2025, Summers County Comprehensive High School athlete Avery Lilly will be trading in her orange and black gear for ...
Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug. Hours after Hims & Hers posted a blog ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...
Eli Lilly experienced a 6% increase in price over the last quarter, coinciding with several major developments. The company reported strong financial results, with significant year-over-year ...
Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug, marketed and sold as Zepbound / Mounjaro. Hims & Hers ...
Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer.